Loading...
Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer
BACKGROUND: The efficacy and safety of chemotherapy (CTx) after anti-PD-1 therapy in patients with advanced gastric cancer (AGC) remains unclear. METHODS: Medical records of consecutive patients with AGC treated with both CTx (taxanes plus ramucirumab, taxanes monotherapy or irinotecan) and anti-PD-...
Na minha lista:
| Udgivet i: | ESMO Open |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7381840/ https://ncbi.nlm.nih.gov/pubmed/32719002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2020-000775 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|